Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
CAPS-consortium adviseert surveillance bij hoog risico op pancreascarcinoom
jan 2020 | Maag-darm-leveroncologie